Exercise Program for Chronic Kidney Disease
(ESTEEM-VIDA Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether a combined exercise program, including aerobic and resistance exercises, can improve muscle function in individuals with chronic kidney disease (CKD) who are not on dialysis. The researchers aim to determine if these exercises can enhance energy use in muscles and improve overall physical activity levels, potentially reducing risks such as disability and hospitalization. Participants will either follow a supervised exercise routine via videoconferencing or receive usual care with general health advice. Individuals with moderate to severe CKD who are not regularly exercising more than once a week might be suitable for this trial. As a Phase 2 trial, this research focuses on measuring the treatment's effectiveness in an initial, smaller group, offering participants a chance to contribute to important findings.
Will I have to stop taking my current medications?
The trial requires that you stop taking certain medications that affect mitochondrial function, such as muscle relaxants, oral steroids, some antiviral medications, oral calcineurin inhibitors, antiepileptic drugs, antipsychotics, anticoagulants, and antiplatelets. If you are on any of these, you may need to stop them to participate.
What prior data suggests that this exercise program is safe for individuals with chronic kidney disease?
Research has shown that both aerobic and resistance exercises are safe for people with chronic kidney disease (CKD). One study found that this type of exercise improved kidney and physical function without causing serious side effects. Another review confirmed that exercise plays a crucial role in breaking the cycle of weakness often seen in CKD. These findings suggest that, when properly supervised, exercise is well-tolerated and beneficial.12345
Why are researchers excited about this trial?
Researchers are excited about this trial because it explores a unique exercise program tailored for individuals with chronic kidney disease (CKD). Unlike standard care, which often focuses on medication and diet control, this approach combines aerobic and resistance exercises delivered via videoconferencing, making it more accessible and adaptable for patients at home. The program involves both supervised and self-directed sessions, providing a balanced mix of guidance and independence. By targeting a specific range of perceived exertion, it aims to optimize physical health without overburdening the body, potentially offering a new way to improve the quality of life for those with CKD.
What evidence suggests that this exercise program is effective for chronic kidney disease?
This trial will compare a Combined Aerobic and Resistance Exercise program with Usual Care for individuals with chronic kidney disease (CKD). Research has shown that combining aerobic and resistance exercises can improve physical abilities in people with CKD. Studies have found that this exercise type supports kidney health and enhances overall quality of life. Regular exercise can ease walking and increase physical strength in patients not on dialysis. It may also slow disease progression and help manage other health issues related to CKD. Overall, participating in a structured exercise program could lead to better health outcomes for those with CKD.36789
Who Is on the Research Team?
Baback Roshanravan, MD MS MSPH
Principal Investigator
UC Davis
Javier Lopez, MD
Principal Investigator
UC Davis Department of Medicine/Division of Cardiology
Are You a Good Fit for This Trial?
This trial is for adults aged 30-75 with moderate to severe chronic kidney disease (CKD) who are not on dialysis and lead a sedentary lifestyle. They must have an eGFR <60ml/min per 1.73m2, not be taking certain medications that affect mitochondria or blood clotting, and cannot have serious heart conditions or other health issues that would make exercise unsafe.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo combined resistance and aerobic exercise supervised by trainers 3 days per week for 12 weeks via videoconferencing, alternating with self-directed sessions.
Follow-up
Participants are monitored for changes in skeletal muscle mitochondrial function, metabolism, and physical function.
What Are the Treatments Tested in This Trial?
Interventions
- Combined Aerobic and Resistance Exercise via videoconferencing
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Davis
Lead Sponsor